All 2025 News
-
SABCS Snippets: Breast Cancer in Younger Patients
Rahul Gosain, MD, of the Oncology Brothers, talks with Virginia Borges, MD, about the increasing number of women under the age of 50 receiving a breast cancer diagnosis.
-
SABCS Snippets: Next Generation Endocrine Therapy
Rahul Gosain, MD, of the Oncology Brothers, talks with Mafalda Oliveira, MD, PhD, about the emerging class of drugs — including oral SERDs and PROTAC estrogen receptor degraders — and whether they are working better for patients.
-
Back-to-back sessions to illuminate ADC complexities, considerations for clinical use
Adrienne G. Waks, MD, will moderate one of two Wednesday afternoon sessions exploring the leading edge of ADC research, including biomarker implications, mechanisms of action, and considerations for the use of ADCs in clinical practice.
-
SABCS Schedule Spotlight for Wednesday, December 10
Plan your Wednesday schedule and don’t miss notable items on the program, including the first General Session, the first Poster Spotlight sessions, and more.
-
State of the Art session to explore how liquid biopsy can guide adaptive therapy
François-Clément Bidard, MD, PhD, will present on Wednesday afternoon about how liquid biopsy can optimize risk assessment and personalize treatment approaches in breast cancer.
-
State of the Art session to shed light on role of non-T cells in modulating TME, anti-tumor responses
Christos Sotiriou, MD, PhD, will moderate a Thursday afternoon session focused on the current understanding of the role of non-T cells in the tumor microenvironment (TME).
-
Welcome to SABCS 2025: Greetings from the symposium co-directors
San Antonio Breast Cancer Symposium co-directors, Carlos Arteaga, MD, and Virginia Kaklamani, MD, are honored to welcome attendees to the preeminent international scientific meeting for breast cancer research.
-
SABCS Schedule Spotlight for Tuesday, December 9
Plan your Tuesday schedule and don’t miss notable items on the program, including concurrent Special Sessions and Educational Sessions that address hot topics in breast cancer.
-
Workshop to explore breast cancer risk assessment and management in women under 40 years
Sonya A. Reid, MD, MPH, will moderate a Tuesday afternoon session exploring the optimal surveillance, imaging, and management strategies for young women at increased risk for breast cancer.
-
Experts to explore steps after CDK4/6 inhibitors in HR-positive, HER2-negative metastatic breast cancer
Antoinette Tan, MD, MHSc, will moderate a Tuesday afternoon session focusing on the evolving second-line treatment options for patients with HR-positive, HER2-negative metastatic breast cancer